SLDB
Solid Biosciences Inc.
Company Overview
| Mkt Cap | $460.98M | Price | $4.39 |
| Volume | 2.32M | Change | -15.58% |
| P/E Ratio | -3.7 | Open | $4.71 |
| Revenue | $963.0K | Prev Close | $5.20 |
| Net Income | $-124.7M | 52W Range | $2.41 - $7.37 |
| Div Yield | N/A | Target | $15.58 |
| Overall | 40 | Value | 60 |
| Quality | 34 | Technical | 27 |
No chart data available
Stock Overview
Updated DailySolid Biosciences Inc. (SLDB) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $4.39 with a market capitalization of $460.98 million. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 34.
Today's trading session shows SLDB with a volume of 2.32 million shares. The stock opened down 9.42% from yesterday's close of $5.20. Current analyst estimates project earnings of $-1.87 per share for this year, with next year targeting $-1.88.
SLDB demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for SLDB include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 254.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 4, 2025 at 09:35 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SLDB | $4.39 | -15.6% | 2.32M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |